Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03233711
Brief Title: Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

First Submitted : July 28, 2017
First Submitted that Met QC Criteria : July 28, 2017
First Posted : July 31, 2017

Last Update Submitted that Met QC Criteria : October 8, 2021
Last Update Posted : October 11, 2021